格隆汇5月7日|梯瓦制药第一季度营收38.9亿美元,预估40亿美元。第一季度调整后每股收益0.52美元。梯瓦制药预计全年营收168亿美元至172亿美元,市场预估172.2亿美元,此前预计168亿美元至174亿美元。梯瓦制药预计全年调整后每股收益2.45美元至2.65美元。梯瓦制药仍然预测全年自由现金流16亿美元至19亿美元。梯瓦制药预计全年调整后EBITDA 47亿美元至50亿美元,市场预估...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.